Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-α, angiostatin, or endostatin

Human Gene Therapy

Volumn 14, Issue 9, 2003, Pages 883-895

  De Boüard, Sophie ^a   Guillamo, Jean Sébastien ^a   Christov, Christo ^a   Lefévre, Nathalie ^a   Brugières, Pierre ^a,b   Gola, Eleonora ^c   Devanz, Pauline ^a   Indraccolo, Stefano ^c,d   Peschanski, Marc ^a  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; ANGIOSTATIN; ENDOSTATIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; BRAIN SLICE; CELL VECTOR; CONTROLLED STUDY; DNA MODIFICATION; DNA VECTOR; GENETIC ENGINEERED CELL; GENETIC ENGINEERING; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SURVIVAL TIME; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VASCULARIZATION; VALIDATION PROCESS;

ANIMALIA;

EID: 0037942860     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403765701178     Document Type: Article

References (52)

1. ADAMS, F., QUESADA, J.R., and GUTTERMAN, J.U. (1984). Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer. JAMA 252, 938-941.
2. BELARDELLI, F., GRESSER, I., MAURY, C., DUVILLARD, P., PRADE, M., and MAUNOURY, M.T. (1983). Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneously. Int. J. Cancer 31, 649-653.
3. BERNSTEIN, J. (1996). Local invasion and intraparenchymal metastasis of astrocytomas. Neuropathol. Appl. Neurobiol. 22, 405-433.
4. BLACK, P. (1991). Brain tumors. N. Engl. J. Med. 324, 1471-1476.
5. BRANCA, A.A., and BAGLIONI, C. (1981). Evidence that types I and II interferons have different receptors. Nature 294, 768-770.
6. BROUTY-BOYE, D., and ZETTER, B.R. (1980). Inhibition of cell motility by interferon. Science 208, 516-518.
7. BUCKNER, J.C., SCHOMBERG, P.J., MCGINNIS, W.L., CASCINO, T.L., SCHEITHAUER, B.W., O'FALLON, J.R., MORTON, R.F., KUROSS, S.A., MAILLIARD, J.A., HATFIELD, A.K., COLE, J.T., STEEN, P.D., and BERNATH, A.M. (2001). A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer 92, 420-433.
8. CHANG, S.M., BARKER II, F.G., HUHN, S.L., NICHOLAS, M.K., PAGE, M., RABBITT, J., and PRADOS, M.D. (1998). High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma. J. Neurooncol. 37, 169-176.
9. CHEKENYA, M., HJELSTUEN, M., ENGER, P.O., THORSEN, F., JACOB, A.L., PROBST, B., HARALDSETH, O., PILKINGTON, G., BUTT, A., LEVINE, J. M., and BJERKVIG, R. (2002). NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin. FASEB J. 16, 586-588.
10. DE BOUARD, S., CHRISTOV, C., GUILLAMO, J.S., KASSAR-DUCHOSSOY, L., PALFI, S., LEGUERINEL, C., MASSET, M., COHEN-HAGENAUER, O., PESCHANSKI, M., and LEFRANCOIS, T. (2002). Invasion of human glioma biopsy specimens in cultures of rodent brain slices: A quantitative analysis. J. Neurosurg. 97, 169-176.
11. DEBAULT, L.E., KAHN, L.E., FROMMES, S.P., and CANCILLA, P.A. (1979). Cerebral microvessels and derived cells in tissue culture: Isolation and preliminary characterization. In Vitro 15, 473-487.
12. DINNEY, C.P., BIELENBERG, D.R., PERROTTE, P., REICH, R., EVE, B.Y., BUCANA, C.D., and FIDLER, I.J. (1998). Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration. Cancer Res. 58, 808-814.
13. DVORAK, H.F., and GRESSER, I. (1989). Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J. Natl. Cancer Inst. 81, 497-502.
14. FOLKMAN, J. (1972). Anti-angiogenesis: New concept for therapy of solid tumors. Ann. Surg. 175, 409-416.
15. FOLKMAN, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31.
16. GOETZ, I.E., WARREN, J., ESTRADA, C., ROBERTS, E., and KRAUSE, D.N. (1985). Long-term serial cultivation of arterial and capillary endothelium from adult bovine brain. In Vitro Cell Dev. Biol. 21, 172-180.
17. GOLDBRUNNER, R.H., WAGNER, S., ROOSEN, K., and TONN, J.C. (2000). Models for assessment of angiogenesis in gliomas. J. Neurooncol. 50, 53-62.
18. GRISCELLI, F., LI, H., BENNACEUR-GRISCELLI, A., SORIA, J., OPOLON, P., SORIA, C., PERRICAUDET, M., YEH, P., and LU, H. (1998). Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. U.S.A. 95, 6367-6372.
19. GUILLAMO, J.S., LISOVOSKI, F., CHRISTOV, C., LE GUERINEL, C., DEFER, G.L., PESCHANSKI, M., and LEFRANCOIS, T. (2001). Migration pathways of human glioblastoma cells xenografted into the immunosuppressed rat brain. J. Neurooncol. 52, 205-215.
20. GUTTERMAN, J.U. (1994). Cytokine therapeutics: Lessons from interferon alpha. Proc. Natl. Acad. Sci. U.S.A. 91, 1198-1205.
21. HANAHAN, D., and FOLKMAN, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
22. HOLASH, J., MAISONPIERRE, P., COMPTON, D., BOLAND, P., ALEXANDER, C., ZAGZAG, D., YANCOPOULOS, G., and WIEGAND, S. (1999). Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284, 1994-1998.
23. HONG, Y., CHUNG, D., JOE, Y., YANG, Y., KIM, K., PARK, Y., YUNG, W., and KANG, J. (2000). Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Clin. Cancer Res. 6, 3354-3360.
24. HORTON, H.M., ANDERSON, D., HERNANDEZ, P., BARNHART, K.M., NORMAN, J.A., and PARKER, S.E. (1999). A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha. Proc. Natl. Acad. Sci. U.S.A. 96, 1553-1558.
25. INDRACCOLO, S., GOLA, E., ROSATO, A., MINUZZO, S., HABELER, W., TISATO, V., RONI, V., ESPOSITO, G., MORINI, M., ALBINI, A., NOONAN, D.M., FERRANTINI, M., AMADORI, A., and CHIECO-BIANCHI, L. (2002). Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. Gene Ther. 9, 867-878.
26. JAIN, R.K. (1991). Haemodynamic and transport barriers to the treatment of solid tumours. Int. J. Radiat. Biol. 60, 85-100.
27. JEREB, B., PETRIC-GRABNAR, G., KLUN, B., LAMOVEC, J., SKRBEC, M., and SOOS, E. (1994). Addition of IFN-alpha to treatment of malignant brain tumors. Acta Oncol. 33, 651-654.
28. JOKI, T., MACHLUF, M., ATALA, A., ZHU, J., SEYFRIED, N.T., DUNN, I.F., ABE, T., CARROLL, R.S., and BLACK, P.M. (2001). Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat. Biotechnol. 19, 35-39.
29. JONES, M.K., WANG, H., PESKAR, B.M., LEVIN, E., ITANI, R.M., SARFEH, I.J., and TARNAWSKI, A.S. (1999). Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat. Med. 5, 1418-1423.
30. KENYON, B.M., VOEST, E.E., CHEN, C.C., FLYNN, E., FOLKMAN, J., and D'AMATO, R.J. (1996). A model of angiogenesis in the mouse cornea. Invest. Ophthalmol. Vis. Sci. 37, 1625-1632.
31. KIRSCH, M., STRASSER, J., ALLENDE, R., BELLO, L., ZHANG, J., and BLACK, P. (1998). Angiostatin suppresses malignant glioma growth in vivo. Cancer Res. 58, 4654-4659.
32. KUNKEL, P., ULBRICHT, U., BOHLEN, P., BROCKMANN, M.A., FILLBRANDT, R., STAVROU, D., WESTPHAL, M., and LAMSZUS, K. (2001). Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res. 61, 6624-6628.
33. KUO, C.J., FARNEBO, F., YU, E.Y., CHRISTOFFERSON, R., SWEARINGEN, R.A., CARTER, R., VON RECUM, H.A., YUAN, J., KAMIHARA, J., FLYNN, E., D'AMATO, R., FOLKMAN, J., and MULLIGAN, R.C. (2001). Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc. Natl. Acad. Sci. U.S.A. 98, 4605-4610.
34. MA, H.I., LIN, S.Z., CHIANG, Y.H., LI, J., CHEN, S.L., TSAO, Y.P., and XIAO, X. (2002). Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector. Gene Ther. 9, 2-11.
35. MCKENNA, R.M. and OBERG, K.E. (1997). Antibodies to interferon-alpha in treated cancer patients: Incidence and significance. J. Interferon Cytokine Res. 17, 141-143.
36. MEYERS, C.A., SCHEIBEL, R.S., and FORMAN, A.D. (1991). Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 41, 672-676.
37. OKADA, H., VILLA, L., ATTANUCCI, J., ERFF, M., FELLOWS, W.K., LOTZE, M.T., POLLACK, I.F., and CHAMBERS, W.H. (2001). Cytokine gene therapy of gliomas: Effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells. Gene Ther. 8, 1157-1166.
38. O'REILLY, M., BOEHM, T., SHING, Y., FUKAI, N., VASIOS, G., LANE, W., FLYNN, E., BIRKHEAD, J., OLSEN, B., and FOLKMAN, J. (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
39. O'REILLY, M., HOLMGREN, L., SHING, Y., CHEN, C., ROSENTHAL, R., MOSES, M., LANE, W., CAO, Y., SAGE, E., and FOLKMAN, J. (1994). Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
40. PLATE, K., and RISAU, W. (1995). Angiogenesis in malignant gliomas. Glia 15, 339-347.
41. RAJKUMAR, S.V., BUCKNER, J.C., SCHOMBERG, P.J., CASCINO, T.L., BURCH, P.A., and DINAPOLI, R.P. (1998). Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma. Int. J. Radiat. Oncol. Biol. Phys. 40, 297-302.
42. READ, T.A., SORENSEN, D.R., MAHESPARAN, R., ENGER, P.O., TIMPL, R., OLSEN, B.R., HJELSTUEN, M.H., HARALDSETH, O., and BJERKVIG, R. (2001). Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat. Biotechnol. 19, 29-34.
43. ROSENSTEIN, J.M., MANI, N., SILVERMAN, W.F., and KRUM, J.M. (1998). Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 95, 7086-7091.
44. RUBENSTEIN, J.L., KIM, J., OZAWA, T., ZHANG, M., WESTPHAL, M., DEEN, D.F., and SHUMAN, M.A. (2000). Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2, 306-314.
45. SCHWARZ, E.J., REGER, R.L., ALEXANDER, G.M., CLASS, R., AZIZI, S.A., and PROCKOP, D.J. (2001). Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro. Gene Ther. 8, 1214-1223.
46. SINGH, R.K., GUTMAN, M., BUCANA, C.D., SANCHEZ, R., LLANSA, N., and FIDLER, I.J. (1995). Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl. Acad. Sci. U.S.A. 92, 4562-4566.
47. SIPOS, E.P., and BREM, H. (2000). Local anti-angiogenic brain tumor therapies. J. Neurooncol. 50, 181-188.
48. SLEDGE, G.W., JR., and MILLER, K.D. (2002). Angiogenesis and antiangiogenic therapy. Curr. Probl. Cancer 26, 1-60.
49. STOPPINI, L., BUCHS, P., and MULLER, D. (1991). A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37, 173-182.
50. TANAKA, T., CAO, Y., FOLKMAN, J., and FINE, H.A. (1998). Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res. 58, 3362-3369.
51. USSON, Y., GUIGNANDON, A., LAROCHE, N., LAFAGE-PROUST, M.H., and VICO, L. (1997). Quantitation of cell-matrix adhesion using confocal image analysis of focal contact associated proteins and interference reflection microscopy. Cytometry 28, 298-304.
52. ZAGZAG, D., AMIRNOVIN, R., GRECO, M., YEE, H., HOLASH, J., WIEGAND, S., ZABSKI, S., YANCOPOULOS, G., and GRUMET, M. (2000). Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis. Lab. Invest. 80, 837-849.